ClinicalTrials.Veeva

Menu

Evaluating the Efficacy of Cranial Electrotherapy Stimulation in Mitigating Anxiety-induced Cognitive Deficits

Tufts University logo

Tufts University

Status

Completed

Conditions

Cognitive Deficit
Anxiety

Treatments

Device: Sham Cranial Electrotherapy Stimulation
Device: Cranial Electrotherapy Stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT04961112
1908026

Details and patient eligibility

About

This study investigates the potential of cranial electrotherapy stimulation to mitigate anxiety induced cognitive deficits

Enrollment

124 patients

Sex

All

Ages

18 to 28 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Between 18-28 years old

Exclusion criteria

  • History of diagnosis with a neurological or psychiatric disorder.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

124 participants in 4 patient groups

Experimental - Induced Anxiety
Experimental group
Description:
Participants will be administered a shock procedure in which they are exposed to safe electrical shock that will be gradually increase from (1) 30 milliseconds to (4) 80 milliseconds to an individual threshold that is uncomfortable but not painful. Participants will be told they may receive additional shocks for poor performance during cognitive assessments. Participants will be administered cranial electrotherapy stimulation with a frequency of .5 Hz and a current of 100 microamps during 30 minutes of cognitive assessments of task switching, inhibition (stroop), working memory (n-back), and processing speed (simple reaction time).
Treatment:
Device: Cranial Electrotherapy Stimulation
Experimental - No Induced Anxiety
Experimental group
Description:
Participants will be administered a shock procedure in which they are exposed to safe electrical shock that will be gradually increase from (1) 30 milliseconds to (4) 80 milliseconds to an individual threshold that is uncomfortable but not painful. After this procedure, the shock belt will be turned off. Participants will be told they will not receive additional shocks during cognitive assessments. Participants will be administered cranial electrotherapy stimulation with a frequency of .5 Hz and a current of 100 microamps during 30 minutes of cognitive assessments of task switching, inhibition (stroop), working memory (n-back), and processing speed (simple reaction time).
Treatment:
Device: Cranial Electrotherapy Stimulation
Sham - Induced Anxiety
Sham Comparator group
Description:
Participants will be administered a shock procedure in which they are exposed to safe electrical shock that will be gradually increase from (1) 30 milliseconds to (4) 80 milliseconds to an individual threshold that is uncomfortable but not painful. Participants will be told they may receive additional shocks for poor performance during cognitive assessments. Participants will be administered sham cranial electrotherapy stimulation with no current during 30 minutes of cognitive assessments of task switching, inhibition (stroop), working memory (n-back), and processing speed (simple reaction time).
Treatment:
Device: Sham Cranial Electrotherapy Stimulation
Sham - No Induced Anxiety
Sham Comparator group
Description:
Participants will be administered a shock procedure in which they are exposed to safe electrical shock that will be gradually increase from (1) 30 milliseconds to (4) 80 milliseconds to an individual threshold that is uncomfortable but not painful. After this procedure, the shock belt will be turned off. Participants will be told they will not receive additional shocks during cognitive assessments. Participants will be administered sham cranial electrotherapy stimulation with no current during 30 minutes of cognitive assessments of task switching, inhibition (stroop), working memory (n-back), and processing speed (simple reaction time).
Treatment:
Device: Sham Cranial Electrotherapy Stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Nathan Ward, PhD; Thomas Wooten, BS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems